Western Wealth Management, LLC Mustang Bio, Inc. Transaction History

Western Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 30, 2023	SELL	$0.32 - $8.0 $14,400 - $360,000	-45,000 Closed	0 $0
Q4 2022 Feb 02, 2023	SELL	$0.32 - $8.27 $14,400 - $372,150	-45,000 Reduced 50.0%	45,000 $17,000
Q3 2022 Nov 04, 2022	BUY	$0.46 - $7.2 $41,400 - $648,000	90,000 New	90,000 $42,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $21M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Western Wealth Management, LLC with notifications on news.